AI leaders call for tougher protections against AI-aided bioweapons
TL;DR
Normally competing AI heavyweights are aligning: Dario Amodei (Anthropic), Sam Altman (OpenAI), and Mustafa Suleyman (Microsoft) are urging the US Congress in an open letter to close a dangerous biosecurity gap. Specifically, sellers of synthetic DNA and RNA would be required to screen orders for risky sequences. The goal is to make it harder to misuse AI to develop biological weapons.
Nauti's Take
Rival AI labs uniting behind biosecurity rules is real progress — a sign the industry takes concrete risks seriously rather than downplaying them. The catch: voluntary appeals don't replace laws, and screening DNA orders can be circumvented.
For the public it's a reassuring signal; for lawmakers it's only the start of a tough regulatory task.